Last updated 48 days ago

A Research Study to See How Much CagriSema (1.0 mg Once Weekly) Lowers Blood Sugar and Body Weight Compared to Tirzepatide (5 mg Once Weekly) in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

1000 patients around the world

Available in Spain, Brazil, Argentina, United States

Novo Nordisk A/S

10Research sites

1000Patients around the world

This study is for people with

Diabetes

Diabetes mellitus type 2

Requirements for the patient

From 18 Years

All Gender

Medical requirements

Sites

Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires

Viamonte 2278, CABA, Buenos Aireswww.cinme.com.ar

Instituto de Investigaciones Clínicas San Nicolás

Pellegrini 346, San Nicolás

Clínica de Fracturas y Ortopedia

Av. Independencia 1475, Mar del Plata, Buenos Aires

Fundación Centro de Salud e Investigaciones Médicas (CESIM)

Urquiza 646, Santa Rosa, La Pampa

Centro de Investigaciones Médicas Tucumán

San Miguel de Tucuman, Tucuman, T4000AXL

Investigaciones Médicas IMOBA SRL

Av. Medrano 134, CABA, Buenos Aires

Centro Médico Cimel Chahin Chahin S.A.

Tucumán 1314, Lanús, Buenos Aires

Centro de Diabetes Curitiba - Curitiba, Parana

Rua Alcidez Munhoz, 433, 4º andar, sala 448, Curitiba, Parana

Núcleo de Pesquisa Clínica do Rio Grande do Sul - NPCRS

Rua Mostardeiro 5/310, Porto Alegre, Rio Grande do Sul

CPQuali Pesquisa Clínica

Avenida Angélica, 916 Conjunto 506 - São Paulo 01228-000

StudyREIMAGINE 5

SponsorNovo Nordisk A/S

Conditions

Diabetes mellitus type 2

Requirements

From 18 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT06534411